Try our Advanced Search for more refined results

Sens. Back PTAB Denial Rules, Drug Pricing Activists Balk

By Dani Kass ( December 4, 2020, 10:59 PM EST) -- The depth of the rift over whether the U.S. Patent and Trademark Office should be denying patent challenges for reasons other than merit came fully to light, as 800 comments over codifying the practice poured in by the Thursday deadline....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!